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Objective. To evaluate virtual patient (VP) programs for injecting equipment provision (IEP) and
opiate substitution therapy (OST) services with respect to confidence and knowledge among prereg-
istration pharmacist trainees.
Methods. Preregistration trainee pharmacists pilot-tested the VP programs and were invited to com-
plete pre/post and 6-month assessments of knowledge and perceived confidence.
Results. One hundred six trainees participated and completed the pre/postassessments. Forty-six
(43.4%) participants repeated the assessments at six months. Scores in perceived confidence increased
in all domains at both time points postprogram. Knowledge scores were greater posteducation than
preeducation. Knowledge scores were also greater six months after education than preeducation.
Knowledge scores at six months were lower than posteducation for both programs.
Conclusion. Virtual patients programs increased preregistration pharmacists’ knowledge and confi-
dence with regard to IEP and OST immediately after use and at six months postprogram. There was
a loss of clinical knowledge over time but confidence change was sustained.
Keywords: e-learning; pharmacy education; simulation; virtual patients; web-based learning.
INTRODUCTION
In Scotland, substance (drugs and alcohol) misuse
services are delivered in nearly all community pharma-
cies, with approximately 84% offering IEP or OST.1 Pa-
tients using these services may also attend hospitals for a
range of reasons, from presentation at accident and emer-
gency to scheduled procedures, and require support from
the pharmacy staff in the hospitals. The vast number of
patients means there is no stereotypical substance mis-
user. The range of substances beingmisused is wide, from
caffeine or tobacco to alcohol, prescribed analgesics and
strong opioids (eg, heroin). Prescription analgesics are
becoming more commonly misused but variation exists
between localities, populations, and cultures.2 The drug
using population is aging and as a result, there is an in-
crease in the number of age-related conditions also being
presented.3
From the turn of the twenty-first century, substance
misuse services delivered at Scottish community pharma-
cies have increased in range and prevalence: not solely
opioid substitution therapy (OST) but injecting equip-
ment provision (IEP), the supervision of disulfiram, and
alcohol brief interventions. All are intended to improve
the health of the population and not just those at the
highest risk.4
Given the increased provision of these services, in
particular OST and IEP, pharmacist education is essential
to deliver safe, effective, and patient-centered care.Many
opioid users feel stigmatized5 as can others using IEP or
other treatment services. Feelings of stigma can be a bar-
rier to treatment progress5 and education should be tar-
geted at the nature of addiction and the opportunities to
put patients at ease.6
Historically, pharmacist education in substance mis-
use allayed some of the concerns and fears staff had and
assisted in reducing prejudices. Staff attitude was cor-
related with service provision and enhanced service
delivery.7 However, evaluation of structured educa-
tional sessions for pharmacists indentified minimal
change in attitude to methadone programs.8 Tradition-
ally, education aimed at addressing these issues has
been either by didactic lecturing, role play scenarios,
or written distance learning materials (eg, NHS Edu-
cation for Scotland (NES) Substance Misuse Pack).9
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Specialist Pharmacists in Substance Misuse (SPiSMs)
deliver lectures at undergraduate level in Scotland, which
are introductory in nature, and also a tutorial during pre-
registration training as part of the NES Pre-Registration
Pharmacist Scheme (PRPS). Some students may obtain
further experience from part-time employment in a com-
munity pharmacy.
Education is evolving with an increased use of tech-
nology. The potential advantages and disadvantages of
using technology in health professions education are
well documented.10-14 The benefits of using technology
include reduced staff time,12 remote accessibility, self
directed and self paced content,8,12 provision of rapid
and up-to-date feedback,10 easily updatable content,10
and delivering a consistent message.15 Educators are
able to monitor learning activities and assess learning
outcomes, while learners experience greater flexibility
and interactivity compared to traditional large group ed-
ucation.14 Reviews attempting to evaluate the effective-
ness of technology in education compared to traditional
educational methods highlight that technology enhanced
methods can be as effective as traditional method.15-19
In the field of substance misuse, online education
for pharmacists has been developed and evaluated in
New Zealand.20 The approach replaced a 3-4 hour train-
ing session and resulted in improved attitudes of trained
community pharmacists toward patients receiving OST,
as well as improvements in confidence and skills. Par-
ticipants stated that the online format was “feasible and
highly acceptable.” In addition to onlinemodules, online
virtual patients are used in educating health profes-
sionals,21,22 with increased use in pharmacy education
over the last decade.23-31 Virtual patient programs allow
learners to gain experience by making and learning from
decisions in a safe environment,25 thus supporting the
active experimentation stage of experiential learning
theory.32 The inclusion of “scenario-based” virtual pa-
tient programs can be effective where strategic, rather
than procedural, learning goals are required. They also
provide an opportunity to experience problems with no
black and white solution,33 a situation pharmacists report
disliking.34
Pharmacists providing substance misuse services
are required tomake ethical decisions, the consequences
of which may be significant. For example, patients who
are stabilized on long-term methadone treatment may
request a supply of clean injecting equipment from phar-
macists providing IEP services. Choosing to supply this
equipment could increase the likelihood of overdose
from the combination of illicit substances and pre-
scribed methadone. Conversely, refusing to supply the
equipment may lead to the transmission of blood borne
infections from equipment sharing. Given the poten-
tial significance of these consequences, virtual patient
technology appears to be well suited for education in
this context. However, there are no published reports of
their use.
The aim of this study was to develop and pilot-test
two scenario-based virtual patient programs to educate
preregistration pharmacists on injecting equipment pro-
vision (IEP) and opiate substitution therapy (OST) ser-
vices in the community pharmacy setting. Preregistration
training in Scotland is a 12-month experiential program
within a patient-facing setting under the supervision of an
appropriately trained pharmacist. Trainees have direct
contact with patients, including those requiring substance
misuse services. This paper describes the implementation
and evaluation of these scenarios aimed at improving pre-
registration pharmacists’ knowledge and confidence in
the provision of these services during a year of experiential
learning.
METHODS
Two virtual patient scenarios relating to IEP and
OST were developed using computer graphics technol-
ogy. This included a motion capture system to acquire
realistic human motion including complex human move-
ment such as injecting drugs. Professional voice artists
were recorded and dubbed onto the high definition pre-
rendered computer animations before embedding all me-
dia into the Adobe Flash, (Adobe Systems Incorporated,
San Jose, CA) runtime environment. This resulted in a vir-
tual patient package that could run on a wider variety of
computer specifications without the need for the latest
graphics card technology (DigitalDesignStudios,Glasgow,
Scotland, UK).
The learning outcomes were developed for NES by
the SPiSMs. Content targeting these outcomes was story
boarded then incorporated into the technology. The pro-
gram was then reviewed by SPiSMs and NES. The pro-
gram included scenarios during which users were
presented periodically with 3-4 choices and the outcome
of their decisionwas played out in the program (Figure 1).
Users were allowed one attempt but all alternative out-
comes were played out following the outcome relating to
the user’s choice. No data were collected relating to
choices made by individual users.
Preregistration trainees were chosen for this pilot
program to give them the experience of providing sub-
stance misuse services without risk of personal or pa-
tient safety. All 106 trainees enrolled in the 2013-2014
NES preregistration training in the west of Scotland
were included. All other trainees and staff were ex-
cluded. Trainees participated in the pilot as part of
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a mandatory educational program. Trainees were allo-
cated to use the program on one of eight sessions,
hosted in a class room environment with a capacity
of 16 trainees in each session. This setting was selected
because there were sufficient computers with ade-
quate hardware and bandwidth specifications, for each
trainee to work individually and IT support was also
available.
To evaluate participant confidence and knowledge
of subject matter, assessments for each scenario were
designed by SPiSMs and piloted by six preregistration
trainees from the year preceding the study cohort. Only
minor typographical changes were made to the assess-
ments, and these trainees were excluded from the study.
The confidence domains were the learning outcomes
for the program and related to respecting patients, iden-
tifying barriers to access of care, identifying drug mis-
use symptoms, developing empathy, and understanding
harm reduction (Table 1). The SPiSMs determined
the underpinning knowledge that is necessary for any
pharmacists to be able to provide such services com-
petently in practice, and this was used to inform the
knowledge-based questions. The finalized assessments
were made available before and immediately after each
scenario was used in the classroom. Participants from
each session took the assessments simultaneously un-
der invigilation.
The same assessments were made available, via an
e-mailed web link, at six months after the trainees had
participated in the classroom session. Participants could
complete the 6-month assessment in their own time.
There was no incentive for trainees to complete this as-
sessment. Assessments contained the same questions at
each time point but participants were unaware of this,
prior to taking them, and participants were not permitted
to take notes during the classroom assessments. For each
scenario, confidence was measured using a group of four
and five questions with a 5-point Likert scale for OST
and IEP, respectively. Knowledge was assessed using 20
multiple-choice questions, subdivided in to five categories,
for each scenario. All assessments were hosted on Quest-
back (Questback, Olso, Norway).
Assessment data were extracted toMicrosoft Excel
and pre/post and 6-month data were matched according
to individual participants before analysis. Wilcoxon
signed rank test was used to investigate the difference
in confidence and knowledge reported at each time
point. For participants who completed all assessments,
a Friedman’s pairwise comparison was used to investi-
gate the overall difference in scores at each time point.
TheWilcoxon signed rank test (with Bonferroni correc-
tion, p50.0167) was used to determine the difference
in score between each assessment. McNemars and Bi-
nomial exact tests were used investigate the difference
between knowledge scores for individual questions,
where appropriate. Formal ethical approval was not
required as the NES research governance group con-
sidered this piece of work as course evaluation. Guid-
ance from the Chief Scientist Office for NHS Scotland
was consulted.
RESULTS
One hundred six preregistration trainees from the
west of Scotland region participated in the pilot pro-
gram and completed the pre/postassessments. Forty-six
(43.4%) trainees completed the assessment at six months.
Figure 1. Example Screenshot of Learner Choices in the Virtual Patient Program.
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All trainees self rated their perceived levels of confi-
dence in specified domains preexperience, postexperi-
ence, and 6months later. Table 1 shows that confidence
increased significantly in all domains after using the
program.
All trainees took the knowledge assessment before
and after the program, and there was a significant in-
crease in test scores immediately after using the program
(Table 2). For the 46 participants who completed the
knowledge assessment pre, post and at 6 months, the
greatest knowledge scores were observed immediately
after completing the program, followed by the scores at
six months. Friedman’s pairwise comparison indicated
a significant difference between the three assessments
for both the IEP (x2564, p,0.001) and OST (x2577,
p,0.001). A pairwise application of the Wilcoxon
signed rank test (with Bonferroni correction, p50.017)
indicated that there was a significant improvement
between prescores and postscores for IEP (Z55.8,
p,0.001) and OST (Z55.9, p,0.001). This was also
true for the preprogram and 6-month scores for IEP
(Z52.6, p,0.017) and OST (Z54.8, p,0.001). How-
ever, there was a significant decrease in scores be-
tween the posttest and 6-month test scores for both
scenarios (IEP, Z55.50, p,0.001: OST, Z55.8, p,0.001).
Analysis of responses to individual questions
revealed there was a significant improvement for the
majority of questions in both scenarios when com-
paring preassessment to postassessment (McNemar’s
test, Tables 3 and 4). There were three of 20 (15%) and
five of 20 (25%) questions that were answered signif-
icantly better at six months than in the preassessment
for the IEP and OST scenarios, respectively (Binomial
exact test, Tables 3 and 4).



























14 (12-16) 19 (17-20) Z58.6a 16 (14-17) Z52.6b Z55.5a
Opioid substitution
(OST)
14 (12-15) 19 (18-20) Z58.9a 16 (14-17) Z54.8a Z55.8a
Significant improvement: a(p,0.001), b(p,0.05)
Table 1. Self-rated Level of Confidence Preintervention, Immediately Postintervention and at Six Months Postintervention
IEP OST




















Understanding the need to respect
for patients irrespective of their
circumstances
4 (4-4) 4 (4-5)a 4 (4-5)b 4 (4-5) 4 (4-5)a 4 (4-5)c
Describing the barriers of
socioeconomic circumstances to
accessing care from a patient’s
perspective
3 (3-4) 4 (4-5)a 4 (4-5)b 4 (4-4) 4 (4-5)a 4 (4-5)b
Recognising drug misuse
symptoms
3 (2-4) 4 (4-5)a 4 (4-5)b 4 (4-4) 4 (4-5)a 4 (4-4)c
Developing empathy
and understanding of the patient’s
lifestyle
4 (3-4) 4 (4-5)a 4 (4-5)b 4 (4-4) 4 (4-5)a 4 (4-5)b
Understanding the meaning of
“harm reduction”
- - - 4 (3-4) 4 (4-5)a 4 (4-5)c
aPosttest confidence was significantly greater than pretest confidence (Wilcoxon signed rank test, p,0.0001)
b6 months confidence was significantly greater than pretest confidence (Wilcoxon signed rank test, p,0.01)
c6 months confidence was significantly greater than pretest confidence (Wilcoxon signed rank test, p,0.05)
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DISCUSSION
The aim of this study was to evaluate two virtual
patient programs for IEP and OST services, with respect
to confidence and knowledge, for preregistration phar-
macist trainees. There was an increase in knowledge and
confidence immediately after use and six months after.
The self-reported level of confidence for learners was
significantly higher immediately after using the virtual
patient program than prior to use. The increased confi-
dence level was maintained six months later. There was
a significant increase in knowledge scores immediately
after using the program than prior to use.
Almost half the trainees completed a knowledge
test at six months after the program and for these par-
ticipants the highest scores were observed immediately
after completing the program, followed by the scores at
sixmonths. There was a significant improvement for the
majority of questions in both scenarios when comparing
pre/postassessments. Generally, at six months the knowl-
edge scores for each questionwere higher than prior to using
the program. Learning during their experience in practice
may have contributed to the retention of knowledge.
Before participating in the program, it was expected
that trainees had had limited experience of providing
substance misuse services. During their 1-year preregis-
tration training, which was work-based in a pharmacy
setting, the participants were likely to have immediate
increased exposure to this patient group. The program
successfully increased the confidence of the trainees
when working with and caring for this patient group
with their self-reported level of confidence score be-
ing significantly higher after using the program in all
areas assessed. Trainees need confidence supporting
this patient group because it can influence pharmacist
involvement in such services.20 In Scotland, there is
little opportunity for pharmacists to avoid providing
substance misuse services.
Within the virtual patient scenarios, learners were
able to watch the consequences of their decisions as phar-
macists being played out within the patient’s home envi-
ronment. Participants reported increased confidence in
developing empathy with this patient group, which may
be because they could appreciate the challenges these
patients encounter at home. The experience may also al-
low future pharmacists to build realistic expectations of
pharmaceutical care with this patient group. The program
supports previous research where education increased
confidence dealing with challenges associated with and
improved attitudes toward this patient group.7,20 This
form of learning also supports the decision-making pro-
cess when dealing with real-life scenarios.
There was a significant increase in knowledge scores
immediately after using the program, with some retention
six months later. In the United Kingdom, services are
deliveredmore frequently in community pharmacies than
specialist centres or clinics. Trainees predominantly ex-
perience this through OST supervised administration and
instalment dispensing. Patients visit the pharmacy more
frequently when initiating therapy, which is a time of
greater risk. National guidelines recommend a minimum
of three months of daily supervision as treatment is ini-
tiated to increase patient safety.35,36 Trainees should be
knowledgeable in this subject area because as they are
likely to experience a daily consultation with these pa-
tients. One strength of the program is that the learners
can test their clinical and ethical decision-making skills,
dynamically controlling the patient story in a simulated
environment.
With IEP, analysis of responses to individual ques-
tions revealed there were three questions answered sig-
nificantly better at six months than in the preassessment.
One was concerning the hepatitis C vaccine, which was
topical at the time of the study. The other two questions
related to heroin administration. This may be a topic that
a substance misuse patient would discuss with a pharma-
cist. For the OST scenario, the questions answered signif-
icantly better at six months were again issues that trainees
may have experienced in practice (eg, using haloperidol
for psychotic episodes).
Although knowledge scores were lower at six months
than immediately after using the program, the majority of
the knowledge scores at this point were higher than the
preassessment scores. Cook et al stated that the majority
of published research outcomes with virtual patient tech-
nology were largely focused on short-term knowledge.22
Our research demonstrates knowledge gains immediately
and at six months.
To our knowledge, there are no published evaluations
of virtual patient technology to support substance misuse
education, this is the only postgraduate research carried out
on studentswith amaster’s degreewho undertook a year of
practical experience afterwards. Jabbur-Lopes et al con-
cluded that more resources should be invested in develop-
ing virtual patient technology specifically for teaching at
a graduate level.37 Cook et al concluded the role of vir-
tual patients in postgraduate and continuing education
requires further study.22
Much of the literature looks at teaching students clin-
ical skills with chronic disease conditions25,38-43 or deter-
mines student satisfactionwith the learning experience44,45
and the perceived value and useability of the virtual patient
tools.46 Our research looked at not only increasing knowl-
edge but improving confidence with a challenging patient
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group. Research could be carried out using this teaching
method in other similarly challenging groups. In response
to the findings of this study, a series of shorter scenarios
relating to recovery and the provision of unscheduled care
services are in development.
A limitation of this study was that not all the partici-
pants completed the 6-month assessment. In addition, the
sample size and the fact that all participants were preregis-
tration traineesmay limit thegeneralizabilityof the findings.
Although this study investigated knowledge and confi-
dence, there was no assessment of competence in practice.
The trainees were practicing in a real-life environ-
ment, which varied depending on the training site(s) and
patient population for each trainee.All trainees in thePRPS
should have had real-life experiencewithOST/IEP service
provision as part of their core training. Therefore, the con-
clusion that knowledge and confidence as a result of the
program is maintained at six months is confounded.
Questions were kept consistent at each assessment
but participants could have checked reference sources
before the 6-month assessment. To minimize this, partic-
ipants were not made aware that they would be asked the
same questions at the 6-month point.
The questions in the assessments were worded in
a multiple true/false format, which limited assessment to
participants’ factual recall of information only. In addition,
the fourquestions in section5of the IEPassessment (Table3)
only assessed the participants’ knowledge of one fact. Fu-
ture studies would benefit from using a format that allows
for the assessment of higher-order thinking.
Future research could also assess if this type of edu-
cation improves competence in practice and, although this
pilot-test was conducted in a class room setting, the same
technology could be used in a large lecture theater, small
group tutorial, or individually on a laptopormobile device.
CONCLUSION
Using a virtual patient programas ameans of training
postgraduate trainees on how to deliver pharmaceutical
care to substancemisuse patientswas successful at increas-
ing confidence and knowledge immediately after and at six
months after the intervention. This study showed a gradual
loss of clinical knowledge over time despite students
maintaining confidence.
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